Share Search
Visit the Share Search
Glaxosmithkline Accounts Summary
| Date of Accounts | 2025 | 2024 | 2024 | 2023 | 2023 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-03-2024 | 31-12-2023 | 30-03-2023 |
| Revenue | 32,667.00 | 31,376.00 | 7,363.00 | 30,328.00 | 6,951.00 |
| Operating Profit / Loss | 7,932.00 | 4,021.00 | 1,490.00 | 6,745.00 | 2,082.00 |
| Net Interest | -532.00 | -547.00 | n/a | -677.00 | n/a |
| Pre Tax Profit | 7,401.00 | 3,477.00 | 1,355.00 | 6,064.00 | 1,907.00 |
| Post Tax Profit | 6,289.00 | 2,951.00 | 1,081.00 | 5,308.00 | 1,631.00 |
| Profit for the Period | 6,289.00 | 2,951.00 | 1,081.00 | 5,308.00 | 1,631.00 |
| Equity Holders of Parent Company | 5,716.00 | 2,575.00 | n/a | 4,928.00 | n/a |
| Minority Interests | 573.00 | 376.00 | n/a | 380.00 | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 141.10p | 63.20p | 25.70p | 121.60p | 149.24p |
| Earnings per Share (Diluted) | 138.80p | 62.20p | 25.40p | 119.90p | 148.03p |
| Earnings per Share (Adjusted) | 172.00p | 159.30p | 43.10p | 155.10p | 150.06p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 141.10p | 63.20p | 25.70p | 121.60p | 149.24p |
| Earnings per Share (Diluted) | 138.80p | 62.20p | 25.40p | 119.90p | 148.03p |
| Earnings per Share (Adjusted) | 172.00p | 159.30p | 43.10p | 155.10p | 150.06p |
| Dividend per Share | 66.00p | 61.00p | n/ap | 58.00p | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-03-2024 | 31-12-2023 | 30-03-2023 |
| Non-Current Assets | |||||
| Intangible Assets | 23,766.00 | 22,497.00 | n/a | 21,579.00 | n/a |
| Property, Plant and Equipment | 10,048.00 | 10,073.00 | n/a | 9,957.00 | n/a |
| Investments | 1,126.00 | 1,196.00 | n/a | 1,192.00 | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | 1.00 | 41,306.00 | n/a | 38,877.00 |
| Other Non-Current Assets | 8,668.00 | 8,699.00 | n/a | 7,633.00 | n/a |
| Total Non-Current Assets | 43,608.00 | 42,466.00 | 41,306.00 | 40,361.00 | 38,877.00 |
| Current Assets | |||||
| Inventories | 5,924.00 | 5,669.00 | n/a | 5,498.00 | n/a |
| Trade and Other Receivables | 7,471.00 | 6,836.00 | n/a | 7,385.00 | n/a |
| Cash at Bank and in Hand | 3,397.00 | 3,870.00 | n/a | 2,936.00 | n/a |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 718.00 | 622.00 | n/a | 2,749.00 | n/a |
| Total Current Assets | 17,510.00 | 16,997.00 | n/a | 18,568.00 | n/a |
| Other Assets | n/a | n/a | n/a | 76.00 | n/a |
| Total Assets | 61,118.00 | 59,463.00 | 58,511.00 | 59,005.00 | 58,596.00 |
| Current Liabilities | |||||
| Borrowings | 3,012.00 | 2,349.00 | n/a | 2,813.00 | n/a |
| Other Current Liabilities | 18,379.00 | 19,348.00 | n/a | 18,255.00 | n/a |
| Total Current Liabilities | 21,391.00 | 21,697.00 | n/a | 21,068.00 | n/a |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 14,708.00 | 14,637.00 | n/a | 15,205.00 | n/a |
| Provisions | 901.00 | 971.00 | n/a | 806.00 | n/a |
| Other Non-Current Liabilities | 8,162.00 | 9,072.00 | n/a | 9,131.00 | n/a |
| Total Non-Current Liabilities | 23,771.00 | 24,680.00 | n/a | 25,142.00 | n/a |
| Net Assets | 15,956.00 | 13,086.00 | 13,229.00 | 12,795.00 | 11,312.00 |
| Capital and Reserves | |||||
| Share Capital | 1,349.00 | 1,348.00 | n/a | 1,348.00 | n/a |
| Share Premium Account | 3,498.00 | 3,473.00 | n/a | 3,451.00 | n/a |
| Other Reserves | 1,321.00 | 1,054.00 | n/a | 1,309.00 | n/a |
| Retained Earnings | 10,209.00 | 7,796.00 | n/a | 7,239.00 | n/a |
| Shareholders Funds | 16,377.00 | 13,671.00 | 13,840.00 | 13,347.00 | 13,347.00 |
| Minority Interests / Other Equity | -421.00 | -585.00 | -611.00 | -552.00 | -552.00 |
| Total Equity | 15,956.00 | 13,086.00 | 13,229.00 | 12,795.00 | 11,312.00 |
| 31-12-2025 | 31-12-2024 | 31-03-2024 | 31-12-2023 | 30-03-2023 | |
| Operating Margin | 24.28% | 12.82% | 20.24% | 22.24% | 29.95% |
| Return on Capital Employed | 73.38% | 47.09% | 41.08% | 67.14% | 68.37% |
| Dividend Cover | 2.61 | 2.61 | 2.87 | 2.67 | 2.64 |
| Dividend Yield | 3.60 | 4.50 | 0.90 | 4.00 | 4.00 |
| PE Ratio | 10.60 | 8.50 | 39.60 | 9.40 | 9.50 |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | -7.58% | n/a% | -4.92% | 35.19% |
| Net Asset Value per Share | -191.60p | -230.88p | 319.16p | -215.50p | 272.91p |